NCT06495463View on ClinicalTrials.gov

Lonsurf® (Trifluridine/Tipiracil) Plus Chemotherapy in Metastatic Colorectal Cancer Prospective Study in Taiwan

NARecruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

March 19, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG

Trifluridine/tipiracil

"Trifluridine/tipiracil 35 mg/m2 PO twice daily on days 1-5 and day 6-14 off~(choose one combination) : oxalipatin 85mg/m2 IV on day 1 every 14 days or irinotecan 100mg/m2 IV on day 1 every 14 days."

Trial Locations (1)

Unknown

RECRUITING

Chang-Gung Memorial Hospital, Linkou, Linkou District

All Listed Sponsors

lead

Chang Gung Memorial Hospital

OTHER